DEUTSCHE BANK AG\ - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 69 filers reported holding RAPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$259,089
-95.2%
15,589
-94.6%
0.00%
-100.0%
Q2 2023$5,393,735
-0.7%
288,435
-2.5%
0.00%0.0%
Q1 2023$5,429,655
-4.2%
295,894
+3.4%
0.00%0.0%
Q4 2022$5,665,532
-17.7%
286,138
+0.1%
0.00%
-25.0%
Q3 2022$6,880,000
+30.4%
285,966
-1.1%
0.00%
+33.3%
Q2 2022$5,277,000
-16.8%
289,114
+0.3%
0.00%0.0%
Q1 2022$6,341,000
-44.6%
288,336
-7.5%
0.00%
-40.0%
Q4 2021$11,453,000
+2389.8%
311,831
+2008.0%
0.01%
Q3 2021$460,000
+13.6%
14,793
+16.1%
0.00%
Q2 2021$405,000
-73.5%
12,744
-81.5%
0.00%
-100.0%
Q1 2021$1,531,000
+225.7%
68,957
+189.9%
0.00%
Q4 2020$470,000
+139.8%
23,786
+290.3%
0.00%
Q3 2020$196,000
+21.0%
6,094
+9.6%
0.00%
Q2 2020$162,000
+1520.0%
5,560
+1032.4%
0.00%
Q1 2020$10,000
-28.6%
491
-5.8%
0.00%
Q4 2019$14,0005210.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders